Niagen Bioscience (NAGE) Equity Income (2015)
Niagen Bioscience (NAGE) posted quarterly Equity Income of -$24286.0 for Q1 2015.
Niagen Bioscience (NAGE) Equity Income (2015) Analysis & Trends
Niagen Bioscience (NAGE) has reported Equity Income for 1 consecutive years, with -$24286.0 the latest figure, recorded in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2015 | -24,286.00 |